Catalytic antibody binding site

The **catalytic antibody binding site** refers to the portion of an antibody (its variable region, made up of hypervariable CDR loops) intentionally designed or naturally evolved to bind and stabilize the transition state of a chemical reaction, thereby catalyzing it—a function known as "abzyme" activity. Unlike conventional antibodies, which only bind antigens, catalytic antibodies can transform substrates through chemical reactions, often using amino acid residues within their binding loops that mimic enzyme active sites. These regions can be engineered via immunization with transition state analogs or genetic modification to introduce catalytic residues. Catalytic antibodies have been explored for therapeutic and diagnostic applications, such as degrading disease-related peptides (e.g., amyloid-β in Alzheimer's disease), but are not themselves traditional drug targets. Rather, their unique binding sites can, in principle, be tailored to perform a range of enzyme-like reactions not catalyzed by natural enzymes.

Other names

Catalytic antibody active siteabzyme binding site

Stabilization of transition states to catalyze chemical reactions (principle borrowed from enzyme catalysis) Substrate binding and chemical transformation within hypervariable loops of the antibody variable region